Osteopontin and Neopterin Predict Stroke Risk in Patients with Prior Stroke or Transient Ischemic Attack. Results of the Analysis of 13 Biomarkers from the SPARCL Study

被引：0
|
作者：
Ganz, Peter
Amarenco, Pierre
Goldstein, Larry B.
Sillesen, Henrik
Bao, Weihang
Preston, Gregory M.
Welch, K. M.
机构：
[1] San Francisco Gen Hosp, San Francisco, CA 94110 USA
[2] Hop Xavier Bichat, Paris, France
[3] Duke Univ, Med Cntr, Durham, NC USA
[4] Univ Copenhagen, Copenhagen, Denmark
[5] Pfizer, New York, NY USA
[6] Rosalind Franklin Univ Med & Sci, N Chicago, IL USA
来源：
CIRCULATION | 2010年 / 122卷 / 21期
关键词：
Biomarkers; Stroke; Cholesterol-lowering drugs; Statins;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A13033
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Association of Osteopontin, Neopterin, and Myeloperoxidase With Stroke Risk in Patients With Prior Stroke or Transient Ischemic Attacks Results of an Analysis of 13 Biomarkers From the Stroke Prevention by Aggressive Reduction in Cholesterol Levels Trial
    Ganz, Peter
    Amarenco, Pierre
    Goldstein, Larry B.
    Sillesen, Henrik
    Bao, Weihang
    Preston, Gregory M.
    Welch, K. Michael A.
    STROKE, 2017, 48 (12) : 3223 - 3231
  • [2] Association of MCP-1, hsCRP, Neopterin, MMP-9 and NT-proBNP With Coronary Heart Disease Risk in Patients With Prior Stroke or Transient Ischemic Attack. Results of the Analysis of 13 Biomarkers From the SPARCL Trial
    Ganz, Peter
    Amarenco, Pierre
    Goldstein, Larry B.
    Sillesen, Henrik
    Bao, Weihang
    Preston, Gregory M.
    Welch, K. M.
    CIRCULATION, 2013, 128 (22)
  • [3] High-dose atorvastatin after stroke or transient ischemic attack. Results of the SPARCL study
    Lyakishev, A. A.
    KARDIOLOGIYA, 2006, 46 (10) : 70 - 71
  • [4] Transient ischemic attack and ischemic stroke patients with or without prior stroke
    Buchwald, F.
    Norrving, B.
    Petersson, J.
    ACTA NEUROLOGICA SCANDINAVICA, 2017, 136 (06): : 654 - 659
  • [5] Activated protein C and risk of stroke and transient ischemic attack.
    vanderBom, JG
    Bots, ML
    Grobbee, DE
    Slagboom, PE
    Haverkate, F
    Meller, P
    Kluft, C
    CIRCULATION, 1996, 93 (03) : 10 - 10
  • [6] Elevated serum neopterin and homocysteine increased the risk of ischemic stroke in patients with transient ischemic attack
    Xie, Jing
    Qiu, Xiandi
    Ji, Chunli
    Liu, Chunhong
    Wu, Yueming
    PTERIDINES, 2019, 30 (01) : 59 - 64
  • [7] ASSOCIATION OF HDL-CHOLESTEROL, ADIPONECTINE, OSTEOPONTIN, NEOPTERIN AND MYELOPEROXIDASE WITH STROKE SEVERITY IN PATIENTS WITH STROKE RECURRENCE: ANALYSIS OF 14 BIOMARKERS FROM THE SPARCL TRIAL
    Meseguer, E.
    Ganz, P.
    Goldstein, L.
    Sillesen, H.
    Bao, W.
    Preston, G. M.
    Welch, M. A.
    Amarenco, P.
    INTERNATIONAL JOURNAL OF STROKE, 2020, 15 (1_SUPPL) : 163 - 164
  • [8] High-dose atorvastatin and risk of atrial fibrillation in patients with prior stroke or transient ischemic attack: Analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial
    Schwartz, Gregory G.
    Chaitman, Bernard R.
    Goldberger, Jeffrey J.
    Messig, Michael
    AMERICAN HEART JOURNAL, 2011, 161 (05) : 993 - 999
  • [9] Coronary risk stratification in patients with ischemic stroke or transient ischemic stroke attack
    Touze, Emmanuel
    Varenne, Olivier
    Calvet, David
    Mas, Jean-Louis
    INTERNATIONAL JOURNAL OF STROKE, 2007, 2 (03) : 177 - 183
  • [10] Effect of High-Dose Atorvastatin on Risk of Atrial Fibrillation in Patients with Prior Stroke or Transient Ischemic Attack: Analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial
    Schwartz, Gregory G.
    Chaitman, Bernard R.
    Goldberger, Jeffrey J.
    Messig, Michael
    CIRCULATION, 2010, 122 (21)
12345